Life Sciences Investor Survey 2020
Interested in receiving the full results of this year’s life sciences investor survey?
Or contact us! See details below or in the documents.
As one of the few focused merchant banks in Europe, Kempen is uniquely positioned as a specialist in the life sciences and healthcare markets. We provide European companies access to a global network of specialist and generalist investors. The team has successfully executed 125 life sciences transactions* since its inception in 2005, and placed over €5.5bn in equity* for European Life Sciences companies and their investors.